InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Pinto Joshua. Director active across 2 companies, notably Neumora Therapeutics, Inc.. Aggregated, 8 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €489k. History available since 14 February 2024. The latest transaction was filed on 17 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Pinto Joshua is associated with Neumora Therapeutics, Inc. as President and with Metsera, Inc. as Director. Across 8 filings in total, the recent sampled filings between 2024-02-16 and 2026-02-19 show 0 EUR of purchases and 488776 EUR of sales, with the dominant transaction nature indicated as sale.